Biomarker Discovery Europe 2008 was arranged in Dublin in the beginning of October and Guro E. Lind participated as an invited speaker from the Department of Cancer Prevention. At the meeting she presented a strategy for identification of novel diagnostic DNA methylation biomarkers in cancer, exemplified by the five promising candidates the Lothe group has discovered for early detection of colorectal tumors.
The meeting took place in a brand new hotel that quite ambitiously opened the same evening all participants arrived. Some technical problems were anticipated, and indeed the wireless network only worked until the second floor, and some of the guests had technical key-card problems denying them access to their room. But Guro was the only one actually having problems getting out of her room. Fortunately she was locked out by a helpful receptionist just in time for her talk.
The meeting was a part of a biomarker discovery series arranged by GCTbio. The next meeting will take place in the end of January 2009 and the Lothe group is again invited to speak. The Dublin conference had approximately 75 participants, and the majority was from large biotech and pharmaceutical companies.
Kranjec C, Oftedal TF, Ovchinnikov KV, da Silva Duarte V, Hermansen S, Kaus-Drobek M, Sabała I, Porcellato D, Carlsen H, Kjos M(2025) An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy Appl Environ Microbiol, e0243324(in press) DOI 10.1128/aem.02433-24, PubMed 40552825
Kresse SH, Thorkildsen EM, Brandt-Winge S, Pharo H, Vedeld HM, Lind GE(2025) Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses Clin Epigenetics, 17(1), 93 DOI 10.1186/s13148-025-01901-4, PubMed 40468374
Osterlund E, Hammarström K, Nunes L, Mathot L, Mezheyeuski A, Sjöblom T, Glimelius B(2025) Primary tumour location, molecular alterations, treatments, and outcome in a population-based metastatic colorectal cancer cohort BJC Rep, 3(1), 38 DOI 10.1038/s44276-025-00156-z, PubMed 40437037